1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics, May 2015 (p100)

Pharmaceutical Analysis & Statistics, May 2015 (p100)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

2971-3000 of about 20 000 reports

Purchase Reports From Reputable Market Research Publishers

Santhera Pharmaceuticals AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Santhera Pharmaceuticals AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, Investment Banking
Barr Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Barr Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

Silence Therapeutics plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Silence Therapeutics plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Cardium Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cardium Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Hikma Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Hikma Pharmaceuticals PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, Electronic Component and Semiconductor, Electronic Component and Semiconductor
Shanghai Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Shanghai Pharmaceutical Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Medicis Pharmaceutical Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Medicis Pharmaceutical Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Novelos Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Novelos Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
BioMarin Pharmaceutical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioMarin Pharmaceutical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Rexahn Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Rexahn Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Clovis Oncology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Clovis Oncology, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : General Medicine and Specialty Medicine, Therapy
  • Countries : United States
DSM Pharmaceutical Products - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

DSM Pharmaceutical Products - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Merz Pharmaceuticals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Merz Pharmaceuticals GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
Corcept Therapeutics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Corcept Therapeutics Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • May 2015
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Therapy
Nanjing Pharmaceutical Co., Ltd. (600713) - Financial and Strategic SWOT Analysis Review

Nanjing Pharmaceutical Co., Ltd. (600713) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2015
  • by Global Data

Nanjing Pharmaceutical Co., Ltd. (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been ...

  • Industries : Pharmaceutical
  • Countries : China
Amphastar Pharmaceuticals, Inc. (AMPH) - Financial and Strategic SWOT Analysis Review

Amphastar Pharmaceuticals, Inc. (AMPH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • May 2015
  • by Global Data

Amphastar Pharmaceuticals, Inc. (AMPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been ...

  • Industries : Pharmaceutical
Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic SWOT Analysis Review

Taiko Pharmaceutical Co.,Ltd. (4574) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Taiko Pharmaceutical Co., Ltd. (Taiko) is a pharmaceutical company. The company manufactures, sells and exports gastrointestinal drugs. It operates through three business fields such as pharmaceuticals ...

  • Industries : Pharmaceutical
Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

Galectin Therapeutics, Inc. (GALT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Galectin Therapeutics, Inc. (Galectin Therapeutics) is a biotechnology company. The company discovers, develops and commercializes therapies for fibrotic disease and cancer. Its products include ...

  • Industries : Therapy
Lijun International Pharmaceutical (Holding) Co., Ltd. (2005) - Financial and Strategic SWOT Analysis Review

Lijun International Pharmaceutical (Holding) Co., Ltd. (2005) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Lijun International Pharmaceutical (Holding) Co., Ltd. (Lijun) is a pharmaceutical company. The company develops, manufactures and markets pharmaceutical products for healthcare markets. Its products ...

  • Industries : Pharmaceutical
Agios Pharmaceuticals, Inc. (AGIO) - Financial and Strategic SWOT Analysis Review

Agios Pharmaceuticals, Inc. (AGIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Agios Pharmaceuticals, Inc. (Agios) is a biopharmaceutical company. The company discovers and develops therapeutics in the field of cancer metabolism. Its services include such as treatment of ...

  • Industries : Pharmaceutical
Cancer Genetics, Inc. (CGIX) - Financial and Strategic SWOT Analysis Review

Cancer Genetics, Inc. (CGIX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Cancer Genetics, Inc. (CGI) is a pharmaceutical company. The company offers DNA-based cancer diagnostics products and services. Its products include DNA-FISH Probes, CGH Microarrays and Next-Generation ...

  • Industries : General Medicine and Specialty Medicine
Cyclacel Pharmaceuticals, Inc. (CYCC) - Financial and Strategic SWOT Analysis Review

Cyclacel Pharmaceuticals, Inc. (CYCC) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Cyclacel Pharmaceuticals, Inc. (Cyclacel Pharmaceuticals) is a pharmaceutical company. The company develops oral therapies for the treatment of cancer and other serious diseases. Its products include ...

  • Industries : Pharmaceutical
InMed Pharmaceuticals Inc. (CBIS) - Financial and Strategic SWOT Analysis Review

InMed Pharmaceuticals Inc. (CBIS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary InMed Pharmaceuticals Inc. (InMed) is a pharmaceutical company. The company develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets. Its products ...

  • Industries : Pharmaceutical
Tianyin Pharmaceutical Co., Inc. (TPI) - Financial and Strategic SWOT Analysis Review

Tianyin Pharmaceutical Co., Inc. (TPI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Tianyin Pharmaceutical Co., Inc. (Tianyin) is a pharmaceutical company. The company develops, manufactures and supplies branded generics, modernized traditional Chinese medicines and active pharmaceutical ...

  • Industries : Pharmaceutical, General Medicine and Specialty Medicine
  • Countries : China
Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review

Merrion Pharmaceuticals Plc (3MP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Merrion Pharmaceuticals Plc (Merrion) is a product development company. It offers prescription pharmaceutical products to meet unmet needs in healthcare. The company develops various drug forms ...

  • Industries : Pharmaceutical
Beximco Pharmaceuticals Ltd. (BXPHARMA) - Financial and Strategic SWOT Analysis Review

Beximco Pharmaceuticals Ltd. (BXPHARMA) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Beximco Pharmaceuticals Ltd. (BPL) is a pharmaceutical company. The company manufactures and exports pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its products include ...

  • Industries : Pharmaceutical
Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic SWOT Analysis Review

Nang Kuang Pharmaceutical Co., Ltd. (1752) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Nang Kuang Pharmaceutical Co., Ltd. (Nang Kuang) is a pharmaceutical company. It carries out the production of injectables. The company’s product portfolio includes large volume parenterals (LVP; ...

  • Industries : Pharmaceutical
Ilyang Pharmaceutical Co., Ltd (007570) - Financial and Strategic SWOT Analysis Review

Ilyang Pharmaceutical Co., Ltd (007570) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Ilyang Pharmaceutical Co., Ltd (Ilyang Pharma) is a pharmaceutical company. The company manufactures and distributes nutritional supplements and over the counter drugs. It offers products through ...

  • Industries : Pharmaceutical
Hubei Biocause Pharmaceutical Co., Ltd. (000627) - Financial and Strategic SWOT Analysis Review

Hubei Biocause Pharmaceutical Co., Ltd. (000627) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Hubei Biocause Pharmaceutical Co., Ltd. (Hubei Biocause) is a pharmaceutical company. The company operates through API division, Drug product division and Chemical Division. Hubei Biocause offers ...

  • Industries : Drug and Medication, Pharmaceutical
Myungmoon pharmaceutical Co.,Ltd. (017180) - Financial and Strategic SWOT Analysis Review

Myungmoon pharmaceutical Co.,Ltd. (017180) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2015
  • by Global Data

Summary Myungmoon pharmaceutical Co., Ltd. (Myungmoon) is a pharmaceutical company. The company manufactures, wholesales, exports and imports pharmaceuticals. It offers ETC and over-the-counter products. ...

  • Industries : Pharmaceutical

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.